http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-101473271-B1
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y02A50-30 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N9-2462 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N15-11 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N15-81 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N15-74 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N9-52 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N9-14 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-31 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N9-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-74 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-81 |
| filingDate | 2009-08-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2014-12-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2014-12-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | KR-101473271-B1 |
| titleOfInvention | Antimicrobial agents |
| abstract | The present invention relates to an endoribine variant comprising endrhycin fused with a peptide stretch having membrane or LPS mitogenic activity. The present invention also relates to a nucleic acid molecule encoding the modified endorhyne variant, a vector comprising the nucleic acid molecule, and a host cell comprising the nucleic acid molecule or the vector. The present invention also relates to a method for producing the endoribine mutant. The present invention also relates to the modified endorhizine variants for use as medicaments, in particular as diagnostic agents, bactericides or cosmetic substances, as medicaments for the treatment or prevention of Gram-negative bacterial infections. The present invention also relates to the elimination, reduction or prevention of Gram-negative bacterial contamination on food, food processing equipment, food processing plants, surfaces in contact with food, medical devices, hospitals and operating rooms. The present invention also relates to the use of endolysin variants as diagnostic means for medicines, foods or feeds, or as environmental diagnostics. Finally, the present invention relates to a pharmaceutical composition comprising said modified endoribine variant. |
| priorityDate | 2008-08-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 880.